|
| 37503540 | A threshold for mitotic activity and post-surgical residual volume defines distinct prognostic groups for astrocytoma IDH-mutant. | | 2023 |
| 36180241 | In Vivo 2-Hydroxyglutarate Monitoring With Edited MR Spectroscopy for the Follow-up of <i>IDH</i>-Mutant Diffuse Gliomas: The <i>IDASPE</i> Prospective Study. | Neurology | 2023 |
| 36302709 | Human pegivirus identified in severe myelitis and optic neuritis in immunocompromised patients: A pathogenic role for a forgotten virus? | Revue Neurologique | 2023 |
| 35953421 | Incidence and characteristics of pseudoprogression in IDH-mutant high-grade gliomas: AÂ POLA network study. | Neuro-Oncology | 2023 |
| 37204066 | T2-Fluid-attenuated inversion recovery (FLAIR) pseudoprogression in patients with anaplastic oligodendrogliomas treated with procarbazine, lomustine and vincristine (PCV) chemotherapy alone. | | 2023 |
| 37262394 | Mismatch Repair Deficiency and Lynch Syndrome Among Adult Patients With Glioma. | | 2023 |
| 35147721 | Hybrid [F]-F-DOPA PET/MRI Interpretation Criteria and Scores for Glioma Follow-up After Radiotherapy. | Clinical Neuroradiology | 2022 |
| 35522558 | Characteristics of Anaplastic Oligodendrogliomas Short-Term Survivors: A POLA Network Study. | Oncologist | 2022 |
| 35725885 | Chemotherapy is an efficient treatment in primary CNS MALT lymphoma. | Journal of Neuro-Oncology | 2022 |
| 36428602 | Characteristics, Patterns of Care and Predictive Geriatric Factors in Elderly Patients Treated for High-Grade -Mutant Gliomas: A French POLA Network Study. | Cancers | 2022 |
| 35038339 | Progressive multifocal leukoencephalopathy after first-line radiotherapy and temozolomide for glioblastoma. | Neuro-Oncology | 2022 |
| 34690007 | The TeloDIAG: how telomeric parameters can help in glioma rapid diagnosis and liquid biopsy approaches. | Annals of Oncology | 2021 |
| 33803924 | An AI-Powered Blood Test to Detect Cancer Using NanoDSF. | Cancers | 2021 |
| 33986314 | Cumulative incidence and risk factors for radiation induced leukoencephalopathy in high grade glioma long term survivors. | Scientific Reports | 2021 |
| 34139485 | European Reference Network for rare adult solid cancers, statement and integration to health care systems of member states: a position paper of the ERN EURACAN. | ESMO Open | 2021 |
| 34088874 | Sustained Tumor Control With MAPK Inhibition in <i>BRAF</i> V600-Mutant Adult Glial and Glioneuronal Tumors. | Neurology | 2021 |
| 32215616 | 5-Azacitidine in patients with IDH1/2-mutant recurrent glioma. | Neuro-Oncology | 2020 |
| 32322066 | Mechanisms and therapeutic implications of hypermutation in gliomas. | Nature | 2020 |
| 31996412 | Germline mutations in the new E1' cryptic exon of the gene in patients with tumours of von Hippel-Lindau disease spectrum or with paraganglioma. | Journal of Medical Genetics | 2020 |
| 31561286 | Ki-67 and MCM6 labeling indices are correlated with overall survival in anaplastic oligodendroglioma, IDH1-mutant and 1p/19q-codeleted: a multicenter study from the French POLA network. | Brain Pathology | 2020 |
| 31346129 | Molecular Profiling Reclassifies Adult Astroblastoma into Known and Clinically Distinct Tumor Entities with Frequent Mitogen-Activated Protein Kinase Pathway Alterations. | Oncologist | 2019 |
| 31832685 | CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDH-mutant gliomas. | Neuro-Oncology | 2019 |
| 35100676 | Successful Targeting of an ATG7-RAF1 Gene Fusion in Anaplastic Pleomorphic Xanthoastrocytoma With Leptomeningeal Dissemination. | JCO Precis Oncol | 2019 |
| 30890548 | Safety and Feasibility of Repeated and Transient Blood-Brain Barrier Disruption by Pulsed Ultrasound in Patients with Recurrent Glioblastoma. | Clinical Cancer Research | 2019 |
| 29522183 | IDH2 mutations are commonly associated with 1p/19q codeletion in diffuse adult gliomas. | Neuro-Oncology | 2018 |
| 30018130 | Machine Learning for Better Prognostic Stratification and Driver Gene Identification Using Somatic Copy Number Variations in Anaplastic Oligodendroglioma. | Oncologist | 2018 |
| 30193580 | Somatostatin receptor 2A protein expression characterizes anaplastic oligodendrogliomas with favorable outcome. | Acta neuropathologica communications | 2018 |
| 29084869 | Early intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with onconeural antibodies. | Journal of Neurology, Neurosurgery and Psychiatry | 2018 |
| 28260120 | Long-term outcomes of refractory neurosarcoidosis treated with infliximab. | Journal of Neurology | 2017 |
| 28638988 | Same-day genomic and epigenomic diagnosis of brain tumors using real-time nanopore sequencing. | Acta Neuropathol | 2017 |
| 28203616 | Paraneoplastic cerebellar degeneration associated with anti-ITPR1 antibodies. | Neurology: Neuroimmunology and NeuroInflammation | 2017 |
| 27543943 | Tumor cells with neuronal intermediate progenitor features define a subgroup of 1p/19q co-deleted anaplastic gliomas. | Brain Pathology | 2017 |
| 27573687 | Prognostic impact of the 2016 WHO classification of diffuse gliomas in the French POLA cohort. | Acta Neuropathol | 2016 |
| 27090007 | Integrated multi-omics analysis of oligodendroglial tumours identifies three subgroups of 1p/19q co-deleted gliomas. | Nat Commun | 2016 |
| 27175000 | Mitotic index, microvascular proliferation, and necrosis define 3 pathological subgroups of prognostic relevance among 1p/19q co-deleted anaplastic oligodendrogliomas. | Neuro Oncol | 2016 |
| 27036230 | Characteristics of gliomas in patients with somatic IDH mosaicism. | Acta neuropathologica communications | 2016 |
| 24876188 | Herpes simplex encephalitis in glioma patients: a challenging diagnosis. | Journal of Neurology, Neurosurgery and Psychiatry | 2015 |
| 25407774 | Prognostic Relevance of Histomolecular Classification of Diffuse Adult High-Grade Gliomas with Necrosis. | Brain Pathol | 2015 |
| 25605950 | Spinal cord tumour misdiagnosed as seropositive neuromyelitis optica spectrum disorder. | Practical Neurology | 2015 |
| 25964574 | Relationships Between Dose Intensity, Toxicity, and Outcome in Patients with Oligodendroglial Tumors Treated with the PCV Regimen. | Anticancer Research | 2015 |
| 26385879 | Allelic loss of 9p21.3 is a prognostic factor in 1p/19q codeleted anaplastic gliomas. | Neurology | 2015 |
| 26068201 | TCF12 is mutated in anaplastic oligodendroglioma. | Nat Commun | 2015 |
| 26537054 | Dramatic worsening of adult-onset X-linked adrenoleukodystrophy after head trauma. | Neurology | 2015 |
| 25139333 | Diagnostic and prognostic value of preoperative combined GFAP, IGFBP-2, and YKL-40 plasma levels in patients with glioblastoma. | Cancer | 2014 |
| 25455381 | [POLA network: a national network for high-grade oligodendroglial tumors]. | Revue Neurologique | 2014 |
| 24353325 | Contrast enhancement in 1p/19q-codeleted anaplastic oligodendrogliomas is associated with 9p loss, genomic instability, and angiogenic gene expression. | Neuro-Oncology | 2014 |
| 24723566 | Mitotic index, microvascular proliferation, and necrosis define 3 groups of 1p/19q codeleted anaplastic oligodendrogliomas associated with different genomic alterations. | Neuro Oncol | 2014 |
| 24739367 | French research infrastructures to develop and validate glioma biomarkers. | Neurosurgery | 2014 |
| 24881245 | [Improving the management of rare brain cancers with the POLA network]. | Revue de l'Infirmiere | 2014 |
| 20556480 | Up-front temozolomide in elderly patients with anaplastic oligodendroglioma and oligoastrocytoma. | Journal of Neuro-Oncology | 2011 |